The Medical Research Council Myeloma IX Trial: New Clinical Insights on the Anticancer Effects of Zoledronic Acid in Patients With Multiple Myeloma

被引：2

作者：

Berenson, James R. ^{[1
]}

机构：

[1] Inst Myeloma & Bone Canc Res, W Hollywood, CA 90069 USA

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2012年 / 12卷 / 01期

关键词：

BONE-MARROW MICROENVIRONMENT; DELTA-T-CELLS; BREAST-CANCER; DOUBLE-BLIND; DOSING REGIMENS; IN-VITRO; BISPHOSPHONATES; DEXAMETHASONE; PRENYLATION; CLODRONATE;

D O I：

10.1016/j.clml.2011.03.025

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

引用

页码：2 / 4

页数：3

共 33 条

[1]

Clinical and immunological evaluation of zoledronate-activated Vγ9γδ T-cell-based immunotherapy for patients with multiple myeloma [J].

Abe, Yu ;

Muto, Masato ;

Nieda, Mie ;

Nakagawa, Yasunori ;

Nicol, Andrew ;

Kaneko, Touru ;

Goto, Shigenori ;

Yokokawa, Kiyoshi ;

Suzuki, Kenshi .

EXPERIMENTAL HEMATOLOGY, 2009, 37 (08) :956-968

[2]

Chemokines in multiple myeloma [J].

Aggarwal, Rohit ;

Ghobrial, Irene A. ;

Roodman, G. David .

EXPERIMENTAL HEMATOLOGY, 2006, 34 (10) :1289-1295

[3]

[Anonymous], 2010, XG PACK INS

[4]

Antitumor effect of zoledronic acid in previously untreated patients with multiple myeloma [J].

Aviles, Agustin ;

Nambo, Maria J. ;

Neri, Natividad ;

Castaneda, Claudia ;

Cleto, Sergio ;

Huerta-Guzman, Judith .

MEDICAL ONCOLOGY, 2007, 24 (02) :227-230

[5]

Berenson J, 2006, 48 ASH ANN M EXP DEC

[6]

Berenson J, 2007, 49 ASH ANN M EXP DEC

[7]

Safety of intravenous and oral bisphosphonates and compliance with dosing regimens [J].

Conte, P ;

Guarneri, V .

ONCOLOGIST, 2004, 9 :28-37

[8]

Zoledronic acid treatment of 5T2MM-bearing mice inhibits the development of myeloma bone disease: Evidence for decreased osteolysis, tumor burden and angiogenesis, and increased survival [J].

Croucher, PI ;

De Raeve, H ;

Perry, MJ ;

Hijzen, A ;

Shipman, CM ;

Lippitt, J ;

Green, J ;

Van Marck, E ;

Van Camp, B ;

Vanderkerken, K .

JOURNAL OF BONE AND MINERAL RESEARCH, 2003, 18 (03) :482-492

[9]

Antitumor effects of clinical dosing regimens of bisphosphonates in experimental breast cancer bone metastasis [J].

Daubine, Florence ;

Le Gall, Celine ;

Gasser, Juerg ;

Green, Jonathan ;

Clezardin, Philippe .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (04) :322-330

[10]

Denosumab versus zoledronic acid for treatment of bone metastases in men with castration-resistant prostate cancer: a randomised, double-blind study [J].

Fizazi, Karim ;

Carducci, Michael ;

Smith, Matthew ;

Damiao, Ronaldo ;

Brown, Janet ;

Karsh, Lawrence ;

Milecki, Piotr ;

Shore, Neal ;

Rader, Michael ;

Wang, Huei ;

Jiang, Qi ;

Tadros, Sylvia ;

Dansey, Roger ;

Goessl, Carsten .

LANCET, 2011, 377 (9768) :813-822

← 1 2 3 4 →